A: As of March 2026, GHK-Cu and other peptides previously on the FDAs Category 2 restricted list are expected to be reclassified to Category 1, which would restore legal access through licensed compounding pharmacies
Check how the medication looks
Drucker (Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, Toronto), was not acknowledged
A Measured, Evidence-Informed Approach The Meadows is taking a measured approach to GLP-1 integration: The science is promising, but still early Patient safety guides every decision Screening, monitoring, and interdisciplinary care are essential Medication is always paired with comprehensive treatment As research evolves, our approach will continue to be refined
GLP-1 & Alcohol: Can You Drink on Ozempic, Wegovy or Zepbound
Most versatile for titration schedules